VIDEO Prof. Javed Butler: The dreamed treatment for heart failure - one drug, one dose, once a day
CredoWeb VIDEO interview with Prof Javed Butler, The University of Mississippi Medical Center, Jackson, US
- Why polypharmacy in treating heart failure is not a problem but a progress? The real problem now is polymorbidity, not polypharmacy, explains Prof Javed Butler. Polypharmacy is when a patient takes 2 or 3 drugs to control a chronic disease. But polypharmacy side effects are manageable and in reality polypharmacy is a blessing that we actually have therapies for patients.
- What is the good news in treatment of patients with heart failure? There is a lot of progress in this area but the latest buzz is that group of medications called SGLT2 inhibitors. They work both for heart failure and diabetes - one drug, one dose, once a day.
- The modern quadriple therapy for HF – why so limited patients in the world are on this therapy? Number 1 issue both with doctors and patients is: the disease has to be treated irrespective of whether a patient has little symptoms or too many symptoms.
- Bio ... ... ...
Esta publicación es para usuarios registrados
Please register or log in with your account to read the full publication.